Recently, transcription factors (Stat3, Smad, AP-1, NF-κB, E2F, MYC, Ets, Notch, FoxO, Wnt, Hdghog, miR-21, k-Ras) have attracted a fair share of attention as a novel drug target for cancer treatment. This evidence concerns the gene MYC and cancer.